Data Availability
Information is available at the Cuban Public Registry of Clinical Trials, included in WHO International Clinical Trials Registry Platform (Soberana 01A, RPCEC https://rpcec.sld.cu/en/trials/RPCEC00000338-En). Other supporting clinical data and documents, including immunological individual data, will be available after publication of this article through direct request to: ochoa{at}finlay.edu.cu or: vicente.verez{at}finlay.edu.cu.
Posted October 05, 2021.
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: safety, reactogenicity and immunogenicity
